LiveBoost: A GB-based prediction system for liver fibrosis in chronic hepatitis B patients in China - A multi-center retrospective study
Authors:
Open Access
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis‐4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: A systemic review and meta‐analysisHepatology, 2014
- The Frequency and Determinants of Liver Stiffness Measurement Failure: A Retrospective Study of “Real-Life” 38,464 ExaminationsPLOS ONE, 2014
- APRI and FIB‐4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS)Journal of Viral Hepatitis, 2014
- An MLP Classifier for Prediction of HBV-Induced Liver Cirrhosis Using Routinely Available Clinical ParametersDisease Markers, 2013
- Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markersBMC Infectious Diseases, 2010
- Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis BDigestive and Liver Disease, 2008
- FIB-4Hepatology, 2007
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006
- Liver fibrosisJournal of Clinical Investigation, 2005
- A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis CHepatology, 2003